William D. Tap, MD, discusses developing treatment opportunities in soft tissue sarcomas.
William D. Tap, MD, medical oncologist, chief, Sarcoma Medical Oncology Service, Memorial Sloan Kettering Cancer Center, discusses developing treatment opportunities in soft tissue sarcomas.
Soft tissue sarcomas represent approximately 80 different diseases, so it is difficult to develop broad treatment approaches, Tap explains. However, the paradigm of soft tissue sarcoma is shifting as nuances within these rare diseases are being better understood.
As such, unique treatment opportunities are being developed internationally for patients with soft tissue sarcomas, Tap says. Broad program project areas are researching drug development and translational medicine to inform how to optimally tailor therapy to individual patients, Tap concludes.